KemPharm adds Tamara Seymour to its Board of Directors as Chair of Audit Committee
– USA, FL – KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced the appointment of Tamara Seymour to its Board of Directors as Chair of the Audit Committee.…